US stock MEIP surges over 33% today, market capitalization rises to $41.24 million
According to ChainCatcher, market sources report that MEI Pharma (NASDAQ: MEIP) surged over 33% today, with its market capitalization rising to $41.2431 million.
Previous reports indicated that Titan Partners Group and crypto investment firm GSR are jointly leading a strategic transformation of U.S. pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. More than $100 million in funding commitments have already been made to the project. Litecoin founder Charlie Lee has agreed to join the MEI Pharma board of directors.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BMNR Chairman: ETH Fair Value Could Reach $10,000–$20,000 in the Next 12 Months as Wall Street Explores ETH Staking
RootData: B3 to Unlock Tokens Worth Approximately $4.38 Million in One Week
A whale deposited 7,500 ETH worth $25.58 million to a CEX 5 hours ago
Trending news
MoreCrypto prices
More
